THE WHAT? Coty Inc. is selling a portion of its Wella stake to IGF Wealth Management. The deal involves a 3.6% stake in Wella, which Coty sells for $150 million.
THE DETAILS? The sale is subject to due diligence and approval from Kohlberg Kravis Roberts & Co. L.P. Once the transaction is completed, Coty will hold a 22.3% stake in Wella, valued at about $900 million. This sale is part of Coty’s broader strategy to reduce its debt, targeting a leverage ratio 3x by the end of CY23.
THE WHY? Coty’s CFO, Laurent Mercier, sees this sale as a strategic move to improve Coty’s financial standing. The company aims to fully divest its remaining Wella stake by CY25, working towards a 2x leverage ratio. This approach is supplemented by planned share buybacks and business expansion.
Buying aesthetics supplies typically involves sourcing these items from licensed distributors, manufacturers, or specialized suppliers who cater specifically to the needs of aesthetic professionals. These supplies are integral to performing aesthetic treatments aimed at enhancing skin appearance, addressing various skin concerns, and improving overall beauty and wellness.
Examples of aesthetics supplies include:
-
Dermal Fillers: Injectable substances used to add volume and reduce wrinkles.
-
Botulinum Toxin (Botox): Injectables used to temporarily relax facial muscles and reduce wrinkles.
-
Laser Devices: Equipment used for hair removal, skin rejuvenation, tattoo removal, and other laser treatments.
-
Chemical Peels: Solutions applied to the skin to exfoliate and improve texture.
-
Microdermabrasion Devices: Tools used for mechanical exfoliation to rejuvenate skin.
-
Microneedling Devices: Devices that create tiny punctures in the skin to stimulate collagen production.
-
Cosmeceuticals: Skincare products that contain biologically active ingredients with pharmaceutical-like benefits.
-
Sterilization and Disinfection Products: Essential for maintaining hygiene and preventing infections in clinical settings.
